What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients

For researchers who are devoting months or years to a project, the reliability of the peptide supplier is as important as the sophistication of the lab equipment itself
Clinical trial activity has been registered but human safety data remains limited
Anti-Inflammatory and Cytoprotective Effects Both BPC-157 and TB-500 demonstrate significant anti-inflammatory and cytoprotective properties that enhance tissue healing while preventing secondary damage
This hormone helps to regulate your blood sugar levels and sends signals to the receptors in your brain that manage appetite
[16] In the liver, growth hormone stimulation could potentially lead to increased IGF-1 synthesis, which then acts in an endocrine manner to promote growth-related processes throughout the body